EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Impact of a smartphone application for appropriate antibiotic prescribing at three tertiary hospitals: an international, multicentre stepped-wedge cluster randomized trial

Ramzy I Helou, Gaud Catho, Lisa Faxén, Marlies Hulscher, Steven Teerenstra, John Conly, Benedikt D Huttner, Thomas Tängdén, Annelies Verbon

Clinical Microbiology and Infection · 2025

DOI: 10.1016/j.cmi.2025.02.026 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Microbiology and Infection, 2025. Verfasst von Ramzy I Helou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: r.helou@erasmusmc…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Smartphone, Mobile Applications, Antimicrobial Stewardship. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ZonMw, Vetenskapsrådet, Erasmus Medisch Centrum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Smartphone applications (apps) for antibiotic prescribing have been studied in observational studies. Here, we assessed whether the use of a smartphone app increased appropriate antibiotic therapy (AAT) in hospitals. METHODS: An antibiotic stewardship app (Firstline.org) was populated with local guidelines and tested in a stepped-wedged cluster randomized trial in three hospitals in the Netherlands, Sweden, and Switzerland. Defined clusters were randomized per hospital for the intervention (use of app) or standard of care. Primary outcome was AAT assessed by chart review in 15 random patients per cluster per intervention period. Secondary outcomes included clinical outcomes and user analytics. A questionnaire identifying barriers to app use was disseminated. Multivariable multilevel logistic models with time periods as fixed effects to adjust for time trend and treatment as fixed effects were employed to estimate the odds ratio of treatment. RESULTS: Twelve clusters in the Netherlands (1085 patients) were included, 12 in Sweden (362 patients) and 8 in Switzerland (653 patients). Overall, AAT was not increased (2.0% [95% CI, -5.92% to 9.97%]) in the intervention arm compared with control across the three centres. Mean frequency of app use by cluster was associated with an AAT increase (1.9% [95% CI, 1.18-2.62%]) across study centres; 3.2% in the Netherlands (p < 0.01), 2.8% in Switzerland (p < 0.01), and remained similar in Sweden (0.4%; p 0.46). No difference was found for the other secondary outcomes. Main barriers for app use reported in the questionnaire were easily forgetting using the app and having other tools to help prescribing antibiotics. DISCUSSION: Overall, the introduction of a stewardship app did not significantly increase AAT, but a prespecified secondary analysis of app use frequency was associated with a small but significant improvement of AAT. Variable uptake of the app, coexisting routes to guidelines and the impact of the COVID-19 pandemic during the trial likely had an impact on the results. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov, trial number NCT03793946.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsSmartphoneMobile ApplicationsAntimicrobial StewardshipHumansMaleFemaleNetherlandsTertiary Care CentersMiddle AgedSwedenAgedSwitzerlandAdultSurveys and Questionnaires

Stichwörter der Autor:innen

Antimicrobial stewardshipClinical decision support systemInfectious diseasesInformation technologySmartphoneapplication

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: r.helou@erasmusmc.nl.
  • Division of Infectious Diseases, Geneva University Hospital and Faculty of Medicine, University of Geneva, Geneva, Switzerland; Infection Control Division, Geneva University Hospital and Faculty of Medicine, University…
  • Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • IQ Health Science Department, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • IQ Health Science Department, Group Biostatistics, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Departments of Medicine, Microbiology, Immunology & Infectious Diseases, and Pathology & Laboratory Medicine, Synder Institute for Chronic Diseases and O'Brien Institute for Public Health, Cumming School of Medicine, Un…

Förderung

  • ZonMw
  • Vetenskapsrådet
  • Erasmus Medisch Centrum
  • Akademiska Sjukhuset
  • JPIAMR
  • Hôpitaux Universitaires de Genève

Zitieren

APA

Helou, R. I., Catho, G., Faxén, L., Hulscher, M., Teerenstra, S., Conly, J., Huttner, B. D., Tängdén, T., & Verbon, A. (2025). Impact of a smartphone application for appropriate antibiotic prescribing at three tertiary hospitals: an international, multicentre stepped-wedge cluster randomized trial. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2025.02.026

Vancouver

Helou RI, Catho G, Faxén L, Hulscher M, Teerenstra S, Conly J, et al. Impact of a smartphone application for appropriate antibiotic prescribing at three tertiary hospitals: an international, multicentre stepped-wedge cluster randomized trial. Clinical Microbiology and Infection. 2025. doi:10.1016/j.cmi.2025.02.026

BibTeX
@article{Helou2025,
  author = {Helou, Ramzy I and Catho, Gaud and Faxén, Lisa and Hulscher, Marlies and Teerenstra, Steven and Conly, John and Huttner, Benedikt D and Tängdén, Thomas and Verbon, Annelies},
  title = {Impact of a smartphone application for appropriate antibiotic prescribing at three tertiary hospitals: an international, multicentre stepped-wedge cluster randomized trial},
  journal = {Clinical Microbiology and Infection},
  year = {2025},
  doi = {10.1016/j.cmi.2025.02.026}
}
Kostenlos starten →